ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

11.85
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Enzymotec Ltd. - Ordinary Shares (delisted) NASDAQ:ENZY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.85 0.05 199,999.95 0 01:00:00

Enzymotec to Report Third Quarter 2015 Financial Results

28/10/2015 8:05pm

GlobeNewswire Inc.


ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more ENZYMOTEC LTD. Charts.

Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the Company will release financial results for the third quarter ended September 30, 2015 on Wednesday, November 11, 2015, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer, will host a conference call to review the financial results.

The conference call is scheduled to begin at 8:30 a.m. ET on Wednesday, November 11, 2015. Participants should dial (877) 359-9508 (United States) or (224) 357-2393 (International) with confirmation code 68587231 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://edge.media-server.com/m/p/8pq5hbsy, and will be archived online within one hour of its completion through November 18, 2015.

About Enzymotec Ltd.

Enzymotec Ltd. is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.

CONTACT: The Ruth Group
         Tram Bui / Lee Roth
         (646) 536-7035/7012
         tbui@theruthgroup.com
         lroth@theruthgroup.com

1 Year ENZYMOTEC LTD. Chart

1 Year ENZYMOTEC LTD. Chart

1 Month ENZYMOTEC LTD. Chart

1 Month ENZYMOTEC LTD. Chart